Showing results (361-370 of 479) with videos related to
Sort By:
Pageof 48
Gene|January 1, 1984
Cloning of eukaryotic genes in single-strand phage vectors: the human interferon genesD W Bowden, J Mao, T Gill, et al.Pharmaceutical Research|May 1, 1997
Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain deliveryP Jolliet, N Simon, F Brée, et al.Oncology Nursing Forum|February 14, 1998
Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four casesS Cabriales, J Bresnahan, D Testa, et al.Journal of Medicinal Chemistry|February 13, 1999
Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonistsA Leonardi, G Motta, C Boi, et al.Revista Da Associacao Medica Brasileira (1992)|December 6, 2018
Opioid tapering and weaning protocols in pediatric critical care units: a systematic reviewPedro Bichaff, Karina T Setani, Emiliana H G Motta, et al.Bioorganic & Medicinal Chemistry|November 1, 1995
Structure-affinity relationships of baclofen and 3-heteroaromatic analoguesB Pirard, P A Carrupt, B Testa, et al.The Journal of Pharmacy and Pharmacology|June 1, 1983
Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the ratS Fleminger, H van de Waterbeemd, N M Rupniak, et al.Journal of Medicinal Chemistry|January 1, 1989
Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonistS Collin, G Evrard, D P Vercauteren, et al.Arzneimittel-Forschung|August 1, 1986
Affinity of pyridylalkylamines for nicotinic, muscarinic and histaminic recognition sites in brain tissue preparationsC Repond, J A Pratt, I P Stolerman, et al.Clinical Neuropharmacology|January 1, 1984
L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's diseaseD R Cooper, C Marrel, B Testa, et al.Pageof 48